Related references
Note: Only part of the references are listed.Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infectivity by Viral Load, S Gene Variants and Demographic Factors, and the Utility of Lateral Flow Devices to Prevent Transmission
Lennard Y. W. Lee et al.
CLINICAL INFECTIOUS DISEASES (2022)
Indirect Protection by Reducing Transmission: Ending the Pandemic With Severe Acute Respiratory Syndrome Coronavirus 2 Vaccination
Aaron Richterman et al.
OPEN FORUM INFECTIOUS DISEASES (2022)
COVID-19 vaccines: where we stand and challenges ahead
Guido Forni et al.
CELL DEATH AND DIFFERENTIATION (2021)
Assessment of the Risk of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Reinfection in an Intense Reexposure Setting
Laith J. Abu-Raddad et al.
CLINICAL INFECTIOUS DISEASES (2021)
Association of Prior SARS-CoV-2 Infection With Risk of Breakthrough Infection Following mRNA Vaccination in Qatar
Laith J. Abu-Raddad et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)
Emergence of SARS-CoV-2 B.1.1.7 Lineage — United States, December 29, 2020–January 12, 2021
Summer E. Galloway et al.
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2021)
Two prolonged viremic SARS-CoV-2 infections with conserved viral genome for two months
Laith J. Abu-Raddad et al.
INFECTION GENETICS AND EVOLUTION (2021)
BNT162b2 and mRNA-1273 COVID-19 vaccine effectiveness against the SARS-CoV-2 Delta variant in Qatar
Patrick Tang et al.
NATURE MEDICINE (2021)
Effect of Delta variant on viral burden and vaccine effectiveness against new SARS-CoV-2 infections in the UK
Koen B. Pouwels et al.
NATURE MEDICINE (2021)
Severity of SARS-CoV-2 Reinfections as Compared with Primary Infections
Laith J. Abu-Raddad et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Efficacy of Natural Immunity against SARS-CoV-2 Reinfection with the Beta Variant
Hiam Chemaitelly et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Waning of BNT162b2 Vaccine Protection against SARS-CoV-2 Infection in Qatar
Hiam Chemaitelly et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Transmission of COVID-19 in 282 clusters in Catalonia, Spain: a cohort study
Michael Marks et al.
LANCET INFECTIOUS DISEASES (2021)
Risk of mortality in patients infected with SARS-CoV-2 variant of concern 202012/1: matched cohort study
Robert Challen et al.
BMJ-BRITISH MEDICAL JOURNAL (2021)
Correlation of SARS-CoV-2-breakthrough infections to time-from-vaccine
Barak Mizrahi et al.
NATURE COMMUNICATIONS (2021)
Mathematical modeling of the SARS-CoV-2 epidemic in Qatar and its impact on the national response to COVID-19
Houssein H. Ayoub et al.
JOURNAL OF GLOBAL HEALTH (2021)
Introduction and expansion of the SARS-CoV-2 B.1.1.7 variant and reinfections in Qatar: A nationally representative cohort study
Laith J. Abu-Raddad et al.
PLOS MEDICINE (2021)
Assessment of protection against reinfection with SARS-CoV-2 among 4 million PCR-tested individuals in Denmark in 2020: a population-level observational study
Christian Holm Hansen et al.
LANCET (2021)
Initial report of decreased SARS-CoV-2 viral load after inoculation with the BNT162b2 vaccine
Matan Levine-Tiefenbrun et al.
NATURE MEDICINE (2021)
Effectiveness of the BNT162b2 Covid-19 Vaccine against the B.1.1.7 and B.1.351 Variants
Laith J. Abu-Raddad et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Characterizing the Qatar advanced-phase SARS-CoV-2 epidemic
Laith J. Abu-Raddad et al.
SCIENTIFIC REPORTS (2021)
SARS-CoV-2 seropositivity and subsequent infection risk in healthy young adults: a prospective cohort study
Andrew Letizia et al.
LANCET RESPIRATORY MEDICINE (2021)
SARS-CoV-2 Infection Is at Herd Immunity in the Majority Segment of the Population of Qatar
Mohamed H. Al-Thani et al.
OPEN FORUM INFECTIOUS DISEASES (2021)
Real-Time SARS-CoV-2 Genotyping by High-Throughput Multiplex PCR Reveals the Epidemiology of the Variants of Concern in Qatar
Mohammad R. Hasan et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2021)
Associations of Vaccination and of Prior Infection With Positive PCR Test Results for SARS-CoV-2 in Airline Passengers Arriving in Qatar
Roberto Bertollini et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)
Information Technology,x and Operations,{ Tulane University, New Orleans, Louisiana
Di Tian et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2021)
Pfizer-BioNTech mRNA BNT162b2 Covid-19 vaccine protection against variants of concern after one versus two doses
Laith J. Abu-Raddad et al.
JOURNAL OF TRAVEL MEDICINE (2021)
mRNA-1273 COVID-19 vaccine effectiveness against the B.1.1.7 and B.1.351 variants and severe COVID-19 disease in Qatar
Hiam Chemaitelly et al.
NATURE MEDICINE (2021)
Resurgence of SARS-CoV-2 Infection in a Highly Vaccinated Health System Workforce
Jocelyn Keehner et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Prevention and Attenuation of Covid-19 with the BNT162b2 and mRNA-1273 Vaccines
Mark G. Thompson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Interpreting vaccine efficacy trial results for infection and transmission
Marc Lipsitch et al.
VACCINE (2021)
SARS-CoV-2, CT-Values, and Infectivity-Conclusions to Be Drawn from Side Observations
Martin Platten et al.
VIRUSES-BASEL (2021)
COVID-19 Vaccine Breakthrough Infections Reported to CDC - United States, January 1-April 30, 2021
Meseret Birhane et al.
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2021)
SARS-CoV-2 seroprevalence in the urban population of Qatar: An analysis of antibody testing on a sample of 112,941 individuals
Peter Coyle et al.
ISCIENCE (2021)
SARS-CoV-2 antibody-positivity protects against reinfection for at least seven months with 95% efficacy
Laith J. Abu-Raddad et al.
ECLINICALMEDICINE (2021)
SARS-CoV-2, SARS-CoV, and MERS-CoV viral load dynamics, duration of viral shedding, and infectiousness: a systematic review and meta-analysis
Muge Cevik et al.
LANCET MICROBE (2021)
Predicting Infectious Severe Acute Respiratory Syndrome Coronavirus 2 From Diagnostic Samples
Jared Bullard et al.
CLINICAL INFECTIOUS DISEASES (2020)
Viral RNA load as determined by cell culture as a management tool for discharge of SARS-CoV-2 patients from infectious disease wards
Bernard La Scola et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2020)
Development and Validation of the Elecsys Anti-SARS-CoV-2 Immunoassay as a Highly Specific Tool for Determining Past Exposure to SARS-CoV-2
Peter Muench et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2020)
Molecular and Serological Tests for COVID-19. A Comparative Review of SARS-CoV-2 Coronavirus Laboratory and Point-of-Care Diagnostics
Robert Kubina et al.
DIAGNOSTICS (2020)
Persistence and Evolution of SARS-CoV-2 in an Immunocompromised Host
Bina Choi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Multi-center nationwide comparison of seven serology assays reveals a SARS-CoV-2 non-responding seronegative subpopulation
Kfir Oved et al.
ECLINICALMEDICINE (2020)
Epidemiological Impact of SARS-CoV-2 Vaccination: Mathematical Modeling Analyses
Monia Makhoul et al.
VACCINES (2020)
Determinants of Per-Coital-Act HIV-1 Infectivity Among African HIV-1-Serodiscordant Couples
James P. Hughes et al.
JOURNAL OF INFECTIOUS DISEASES (2012)
Viral load and heterosexual transmission of human immunodeficiency virus type 1
TC Quinn et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)